Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis.
作者信息
Zeng Georgia, Gill Upkar S, Kennedy Patrick T F
机构信息
Faculty of Medicine, UNSW, Sydney, New South Wales, Australia.
Barts Liver Centre, Immunobiology, Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
出版信息
Gut. 2020 Nov;69(11):1907-1912. doi: 10.1136/gutjnl-2020-321627. Epub 2020 May 25.
Abstract
摘要
相似文献
1
Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis.
Gut. 2020 Nov;69(11):1907-1912. doi: 10.1136/gutjnl-2020-321627. Epub 2020 May 25.
2
Hepatocellular carcinoma: global epidemiology.
Dig Liver Dis. 2001 Mar;33(2):115-7. doi: 10.1016/s1590-8658(01)80062-1.
3
Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.
Semin Liver Dis. 2010 Feb;30(1):3-16. doi: 10.1055/s-0030-1247128. Epub 2010 Feb 19.
4
Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitis.
Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1277-1282. doi: 10.1097/MEG.0000000000001254.
5
Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy.
J Gastroenterol Hepatol. 2019 Feb;34(2):442-449. doi: 10.1111/jgh.14372. Epub 2018 Jul 19.
6
HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
J Viral Hepat. 2005 May;12(3):325-9. doi: 10.1111/j.1365-2893.2005.00586.x.
7
Comment on: Personal protective equipment (PPE) for surgeons during COVID-19 pandemic: systematic review of availability, usage and rationing.
Br J Surg. 2020 Dec;107(13):e650. doi: 10.1002/bjs.11980. Epub 2020 Oct 1.
8
COVID-19: Perspectives on the Potential Novel Global Threat.
Rev Recent Clin Trials. 2020;15(2):84-86. doi: 10.2174/1574887115999200228100745.
9
Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.
Liver Int. 2018 Jan;38(1):68-75. doi: 10.1111/liv.13489. Epub 2017 Jul 3.
10
The Effects of a Novel Global Pandemic (COVID-19) on a Plastic Surgery Department.
Aesthet Surg J. 2020 Jun 15;40(7):NP423-NP425. doi: 10.1093/asj/sjaa074.
引用本文的文献
1
Evaluation of PAGE-B Score for Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients: Reliability, Validity, and Responsiveness.
Biomedicines. 2024 Jun 5;12(6):1260. doi: 10.3390/biomedicines12061260.
2
Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma.
J Clin Med. 2022 Jul 31;11(15):4475. doi: 10.3390/jcm11154475.
3
Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma.
Nat Rev Gastroenterol Hepatol. 2022 Oct;19(10):670-681. doi: 10.1038/s41575-022-00620-y. Epub 2022 Jun 8.
4
Screening, Surveillance, and Management of Hepatocellular Carcinoma During the COVID-19 Pandemic: a Narrative Review.
J Gastrointest Cancer. 2023 Jun;54(2):408-419. doi: 10.1007/s12029-022-00830-2. Epub 2022 May 2.
5
Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
Int J Mol Sci. 2022 Jan 2;23(1):500. doi: 10.3390/ijms23010500.
6
Screening for Hepatocellular Carcinoma in Patients with Hepatitis B.
Viruses. 2021 Jul 8;13(7):1318. doi: 10.3390/v13071318.
7
Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease.
Aging (Albany NY). 2021 Jun 27;13(12):15785-15800. doi: 10.18632/aging.203220.
8
Assessing efficacy of hepatocellular carcinoma prediction scores to prioritise hepatitis B surveillance in the COVID-19 era.
GastroHep. 2021 Mar;3(2):80-87. doi: 10.1002/ygh2.443. Epub 2021 Feb 24.
9
Surveillance for hepatocellular carcinoma in patients with advanced liver fibrosis.
Saudi J Gastroenterol. 2021 Mar-Apr;27(2):64-72. doi: 10.4103/sjg.sjg_636_20.
本文引用的文献
1
Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study.
J Infect Dis. 2022 Jun 1;225(11):1967-1973. doi: 10.1093/infdis/jiaa192.
2
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.
Gastroenterology. 2020 Aug;159(2):652-664. doi: 10.1053/j.gastro.2020.04.019. Epub 2020 Apr 14.
3
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.
JHEP Rep. 2020 Jun;2(3):100113. doi: 10.1016/j.jhepr.2020.100113. Epub 2020 Apr 2.
4
Monitoring transmissibility and mortality of COVID-19 in Europe.
Int J Infect Dis. 2020 Jun;95:311-315. doi: 10.1016/j.ijid.2020.03.050. Epub 2020 Mar 28.
5
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346. doi: 10.15585/mmwr.mm6912e2.
6
WHO Declares COVID-19 a Pandemic.
Acta Biomed. 2020 Mar 19;91(1):157-160. doi: 10.23750/abm.v91i1.9397.
7
COVID-19 and Italy: what next?
Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13.
8
Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load.
JHEP Rep. 2019 Mar 19;1(1):9-16. doi: 10.1016/j.jhepr.2019.02.002. eCollection 2019 May.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
Gastroenterology. 2019 Dec;157(6):1518-1529.e3. doi: 10.1053/j.gastro.2019.08.028. Epub 2019 Aug 27.
Zotero 插件